JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
Edgewise Therapeutics
EWTX
$4.31B
| $781K | ﹤0.01% |
42,833
+2,770
| +7% | +$44K |
2021 Q2
11 quarters
|
|
4327
Northern Trust Quality Dividend ETF
QDF
$2.2B
| $779K | ﹤0.01% |
11,822
-1,200
| -9% | -$76K |
2022 Q3
6 quarters
|
|
4328
Vanguard ESG International Stock ETF
VSGX
$6.66B
| $779K | ﹤0.01% |
13,554
-15,133
| -53% | -$841K |
2022 Q4
5 quarters
|
|
4329
FT Vest US Equity Buffer ETF June
FJUN
$1.44B
| $779K | ﹤0.01% |
16,559
+15,755
| +1,960% | +$717K |
2022 Q4
5 quarters
|
|
4330
SelectQuote
SLQT
$66M
| $779K | ﹤0.01% |
389,272
+117,328
| +43% | +$175K |
2020 Q2
15 quarters
|
|
|
SRDX
4331
DELISTED
Surmodics
SRDX
| $778K | ﹤0.01% |
26,523
+12,203
| +85% | +$389K |
2013 Q2
43 quarters
|
|
4332
PUT
NetEase
NTES
$77.1B
| $776K | ﹤0.01% |
+7,500
| New | +$767K |
2024 Q1
0 quarters
|
|
4333
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.22M
| $776K | ﹤0.01% |
17,783
| – | – |
2023 Q4
1 quarter
|
|
4334
ProShares Ultra S&P500
SSO
$8.78B
| $776K | ﹤0.01% |
20,010
-2,258
| -10% | -$79.9K |
2022 Q4
5 quarters
|
|
4335
Global X SuperDividend US ETF
DIV
$758M
| $775K | ﹤0.01% |
44,561
-7
| -0% | -$119 |
2020 Q2
15 quarters
|
|
4336
iShares US Pharmaceuticals ETF
IHE
$1.62B
| $772K | ﹤0.01% |
11,378
-754
| -6% | -$49.8K |
2014 Q1
40 quarters
|
|
4337
MiMedx Group
MDXG
$676M
| $765K | ﹤0.01% |
99,345
+22,989
| +30% | +$185K |
2020 Q4
13 quarters
|
|
4338
Disc Medicine
IRON
$2.36B
| $764K | ﹤0.01% |
12,273
-3,756
| -23% | -$244K |
2023 Q2
3 quarters
|
|
4339
SmartRent
SMRT
$228M
| $762K | ﹤0.01% |
284,206
+162,143
| +133% | +$469K |
2021 Q3
10 quarters
|
|
4340
Arcus Biosciences
RCUS
$3.12B
| $759K | ﹤0.01% |
40,226
-39,662
| -50% | -$686K |
2018 Q1
24 quarters
|
|
|
MSB
4341
Mesabi Trust
MSB
$243M
| $758K | ﹤0.01% |
42,818
-3,220
| -7% | -$61.1K |
2021 Q1
12 quarters
|
|
|
ARR
4342
Armour Residential REIT
ARR
$1.88B
| $757K | ﹤0.01% |
38,305
-83,527
| -69% | -$1.61M |
2015 Q3
34 quarters
|
|
4343
Global X Silver Miners ETF NEW
SIL
$4.3B
| $753K | ﹤0.01% |
27,405
-2,737
| -9% | -$69.3K |
2018 Q2
23 quarters
|
|
4344
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.4B
| $752K | ﹤0.01% |
27,077
-2,177
| -7% | -$58.8K |
2022 Q3
6 quarters
|
|
|
NOTV
4345
DELISTED
Inotiv
NOTV
| $751K | ﹤0.01% |
68,664
+68,429
| +29,119% | +$409K |
2015 Q4
33 quarters
|
|
|
GRSD
4346
Grandstand Ltd
GRSD
$52.7M
| $748K | ﹤0.01% |
81,941
+70,934
| +644% | +$643K |
2022 Q2
7 quarters
|
|
4347
iShares US Tech Breakthrough Multisector ETF
TECB
$524M
| $748K | ﹤0.01% |
15,618
+15,536
| +18,946% | +$716K |
2023 Q2
3 quarters
|
|
4348
Tejon Ranch
TRC
$438M
| $746K | ﹤0.01% |
48,431
+19,908
| +70% | +$322K |
2015 Q4
33 quarters
|
|
4349
McEwen Inc
MUX
$1.06B
| $745K | ﹤0.01% |
75,569
-5,027
| -6% | -$36.3K |
2020 Q1
16 quarters
|
|
4350
Expro Ltd
XPRO
$1.72B
| $743K | ﹤0.01% |
37,230
-24,148
| -39% | -$433K |
2017 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.